Articles on cancer biology, molecular diagnostics, forensic genomics, toxicology, science education, and public health in Libya.
Browse the blog by keyword.
Short summaries of newly published papers and science news in molecular biology, molecular genetics, biotechnology and molecular therapeutics.
Across 14 tumor types, a glutaminolysis signature fell with PTEN loss. Neighboring genes with no glutaminolysis role tracked PTEN just as closely, pointing to co-deletion on chromosome 10q.
In glutamine-starved mouse hybridoma cells, ammonium salts raised viability and reduced nuclear fragmentation, yet did not block caspase-3 activation or cytochrome c release.
How the anti-apoptotic protein MCL-1 and the drug obatoclax shape the survival of glutamine-starved cells, in a mouse hybridoma model.
A phase 1 trial of oral glutamine with standard chemotherapy in 16 people with advanced pancreatic cancer reached its planned dose. It cannot show whether the combination works.
Glutamine is an amino acid the body can make, yet many cancer cells in the laboratory fail to grow without it. What do we know about why?
How our team restored a dormant forensic genomics system that went on to help identify remains of people missing since the 2011 conflict.
Reflections on leading curriculum reform across four departments at the Faculty of Biomedical Sciences, University of Benghazi.
Why terrestrial isopods are valuable sentinel organisms for chronic and acute toxicity assessment of agricultural chemicals.
Key findings from our cross-sectional study on breast cancer awareness, early detection practices, and risk factor knowledge in Benghazi.